1. Home >
  2. Companies >
  3. Life Science >
  4. Germany >
  5. Baliopharm AG

Baliopharm AG - Ownership and Business Overview

Life ScienceCompany

Baliopharm AG Ownership

Who owns Baliopharm AG?

Baliopharm AG is owned by Promethera Biosciences SA. It was acquired on April 10, 2018.

Baliopharm AG Business Overview

Where is Baliopharm AG headquartered?

Baliopharm AG is headquartered in Basel, Germany.

What sector is Baliopharm AG in?

Baliopharm AG is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Subscribe to Mergr to view all 250 acquisitions of life science companies in 2018, including 46 acquisitions by private equity firms, and 204 by strategics.

Baliopharm AG

Stanzlergasse 4,
Basel, CH-4051
Germany,
+41 61 2053 910
www.baliopharm.com

Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 1 - - - - - 1
  1

Most Recent M&A

Company Date Value Type
Baliopharm GmbH 2016-05-18 - Divestiture
Juelich, Germany
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) -
Total - - 1 -

By Geo

State/Country Buy Value Sell Value
Germany - - 1 -
Total - - 1 -

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Baliopharm AG

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal